Sangamo Therapeutics (SGMO)

$0.11 -0.07 (-37.27%)
Market Cap 73.58M
Revenue (ttm) 39.55M
Net Income (ttm) -122.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -310.82%
Debt to Equity Ratio 0.00
Volume 44,541,699
Avg Vol 10,731,998
Day's Range N/A - N/A
Shares Out 414.28M
Stochastic %K 4%
Beta 1.04
Analysts Sell
Price Target $3.75

Company Profile

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; small fiber neuropathy for chronic neuropathic pain, and prion disease; Phase 1/2 clinical trial to evaluate the...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 970 6000
Address:
501 Canal Blvd, Richmond, United States
Patrick2343
Patrick2343 Jul. 21 at 2:34 PM
$SGMO if nobody bids their greed will not matter at all. It all comes down to bids and LLY is banking on nobody else bidding.
1 · Reply
Patrick2343
Patrick2343 Jul. 21 at 2:33 PM
$SGMO NO more stalking horses I guess. Not sure whey they moved the deadline if they did not think they would get anymore. Depressing.
1 · Reply
ican
ican Jul. 21 at 10:53 AM
$SGMO per Franca-ole on X https://x.com/Franca_ole/status/2079381092298039749, copy and paste in your browser. per march 31, 2026 filing they will count as ordinary share holders, I think help is on the way, and not because they really care for the rest of us shareholders. That is okay all we needed was someone else's greed.
1 · Reply
rjalagam9111
rjalagam9111 Jul. 21 at 2:06 AM
$SGMO Sandy is a dead man walking for the rest of his life.
1 · Reply
ican
ican Jul. 20 at 10:55 PM
$SGMO https://aum13f.com/firm/armistice-capital-llc Armstice capital profile
2 · Reply
jlemx
jlemx Jul. 20 at 10:18 PM
$SGMO Today, the judge granted Armistice Capital's request to be represented in the auction proceedings. Evidently, Armistice believes there is a chance of obtaining something from Chapter 11 for the SHs as well.
2 · Reply
gimoozaabi
gimoozaabi Jul. 20 at 9:43 PM
$SGMO
0 · Reply
gimoozaabi
gimoozaabi Jul. 20 at 9:38 PM
$SGMO Eli Lilly & Company: Bidding for the Capsid Delivery platform, Zinc Finger platform, Modular Integrase (MINT) platform, and the ST-506 (prion disease) program. Astellas Pharma: Bidding for the Fabry disease program (isaralgagene civaparvovec / ST-920). Other Assets Up for Bidding: Assets not included in the stalking horse bids (such as the ST-503 chronic pain program, giroctocogene fitelparvovec Hemophilia A program, and Treg/cell therapy platforms) are open for standalone third-party bids.
1 · Reply
gimoozaabi
gimoozaabi Jul. 20 at 9:28 PM
$SGMO
0 · Reply
Patrick2343
Patrick2343 Jul. 20 at 8:08 PM
$SGMO We cannot even get another stocking horse bid and you are claiming we will get over a buck each. Seems delusional
0 · Reply
Latest News on SGMO
No data available.
Patrick2343
Patrick2343 Jul. 21 at 2:34 PM
$SGMO if nobody bids their greed will not matter at all. It all comes down to bids and LLY is banking on nobody else bidding.
1 · Reply
Patrick2343
Patrick2343 Jul. 21 at 2:33 PM
$SGMO NO more stalking horses I guess. Not sure whey they moved the deadline if they did not think they would get anymore. Depressing.
1 · Reply
ican
ican Jul. 21 at 10:53 AM
$SGMO per Franca-ole on X https://x.com/Franca_ole/status/2079381092298039749, copy and paste in your browser. per march 31, 2026 filing they will count as ordinary share holders, I think help is on the way, and not because they really care for the rest of us shareholders. That is okay all we needed was someone else's greed.
1 · Reply
rjalagam9111
rjalagam9111 Jul. 21 at 2:06 AM
$SGMO Sandy is a dead man walking for the rest of his life.
1 · Reply
ican
ican Jul. 20 at 10:55 PM
$SGMO https://aum13f.com/firm/armistice-capital-llc Armstice capital profile
2 · Reply
jlemx
jlemx Jul. 20 at 10:18 PM
$SGMO Today, the judge granted Armistice Capital's request to be represented in the auction proceedings. Evidently, Armistice believes there is a chance of obtaining something from Chapter 11 for the SHs as well.
2 · Reply
gimoozaabi
gimoozaabi Jul. 20 at 9:43 PM
$SGMO
0 · Reply
gimoozaabi
gimoozaabi Jul. 20 at 9:38 PM
$SGMO Eli Lilly & Company: Bidding for the Capsid Delivery platform, Zinc Finger platform, Modular Integrase (MINT) platform, and the ST-506 (prion disease) program. Astellas Pharma: Bidding for the Fabry disease program (isaralgagene civaparvovec / ST-920). Other Assets Up for Bidding: Assets not included in the stalking horse bids (such as the ST-503 chronic pain program, giroctocogene fitelparvovec Hemophilia A program, and Treg/cell therapy platforms) are open for standalone third-party bids.
1 · Reply
gimoozaabi
gimoozaabi Jul. 20 at 9:28 PM
$SGMO
0 · Reply
Patrick2343
Patrick2343 Jul. 20 at 8:08 PM
$SGMO We cannot even get another stocking horse bid and you are claiming we will get over a buck each. Seems delusional
0 · Reply
BuyLoSaleHi
BuyLoSaleHi Jul. 20 at 7:04 PM
$SGMO Should we we think of the swings 5-9. Or hold …today is good 20%. Given the consideration of bankruptcy court and the division on multiple vaccines and drugs. Are we to consider or favor in the possibility of a FDA approval possibly happen throughout this process while still in court right now. The approval could’ve taken us over $5 plus before. It’s a shame what Sandy did to this company. I said it before a scientist should had stayed on and let a real CEO come in and handle this debacle. Jboss? Hope you’re right over a dollar scenario. This has to be the worst pharmaceutical debacle in history. I we all of this bankruptcy ok. These drugs and therapies are being sold for pennies of a dolllar. It’s seems like we’re back to swings. We need a constant swing from 9-13…. 13-19.., 19-31 plus and up, I don’t think welll hit a 1$ instantaneous. Still a bunch of millionaires and losers from this company. Best deal ever for day trading for the past few years. Another drop below would.buy.
0 · Reply
Patrick2343
Patrick2343 Jul. 20 at 6:42 PM
$SGMO So it appears no more salking horse bids. I cannot say I am that surprised everything sandy touches turns to s...
0 · Reply
Jbosskief1
Jbosskief1 Jul. 20 at 6:11 PM
$SGMO Just completed an in house estimate with my team, we have SGMO valued at around $1.08 taking all their debt into consideration.
5 · Reply
Patrick2343
Patrick2343 Jul. 20 at 4:16 PM
$SGMO If we hear nothign to day you ccan assume nobody was interested
0 · Reply
Patrick2343
Patrick2343 Jul. 20 at 4:14 PM
$SGMO Can someone explain to me what exactly the company is currently doing with this 30 million they got. They clearly are not working on the CMC it should alrady have been submiteed. SO are they just sitting around getting paid to do nothing ?
1 · Reply
Mr_Mxyzptlk
Mr_Mxyzptlk Jul. 20 at 1:02 PM
$SGMO Today is the stalking horse deadline. So far, no buzz, no leaks....amazingly airtight or no new SH? They have 24-48 hours to disclose.
5 · Reply
rjalagam9111
rjalagam9111 Jul. 20 at 1:01 PM
$SGMO Sandy abandoned ship in the middle of ocean.
1 · Reply
TGTT888
TGTT888 Jul. 19 at 6:16 PM
$SGMO I believe Roche will submit a comprehensive offer. Roche is the only candidate for whom all the assets would be a good fit. The advantage for Roche would be that they would also beat out Eli Lilly.
2 · Reply
Chipoo
Chipoo Jul. 18 at 3:43 PM
$SGMO Alexion would want Fabry. I expect a bid from them. For STAC-BBB, I assume it depends on what success current partners have had. They could at least bid a few millstone payments. SGMO has a bunch a cargo, sitting ready for STAC-BBB. NAV1.7 is a wildcard. If they dosed a few and the data looks good, someone will bid. I doubt there is a bid if they never dosed. My hope is some wises up and realizes a buyout at 500 million would be paid for with Fabry and tax harvesting. Sandy could have sold this company for billions is Fabry was approved, what a twat.
1 · Reply
JimiJoJeeter
JimiJoJeeter Jul. 18 at 1:55 PM
$SGMO I had to send this email 3 times because of my poor editing and fat-fingering on my phone.... my final email to Sangamo: To whoever remains; Well, I'm certain this email will go nowhere. The CEO and BOD have ended where I was demanded they go all along. except with a twist of forced sale. I thought that in order to avoid an inevitable Reverse Split and Raise, a sale while you were in control was better than no control (auction). That would have been the first responsible thing to do. The second responsible thing would have been the RS&R. But of course, an ignorant CEO and a clown car BOD have done everything wrong they could. And, here we are. What an absolute embarrassment. Not to mention the other biotech business managers laughing their asses off at how incompetent and dumb you were. FFS.... you suck!
0 · Reply
Patrick2343
Patrick2343 Jul. 18 at 8:23 AM
$SGMO sandy is like elizabeth holmes wanted some great world but was in delusions and spent money like crazy. He has not been arrested yet but he is like her.
0 · Reply
Wischmop
Wischmop Jul. 17 at 9:56 PM
$SGMO Technology for crossing the blood-brain barrier is highly sought after. The focus has shifted in recent years: Old: Only antibodies targeting amyloid-beta plaques. New: Antibodies targeting tau protein, anti-inflammatories for the brain, gene therapies, and the technology to efficiently transport these drugs across the blood-brain barrier. Biogen and Eisai haven't been particularly successful so far and could certainly put those patents to good use. Novartis is also conducting research in this area, as are AbbVie, Johnson & Johnson, and BMS (focusing on tau protein and neuroinflammatory approaches). And now, let's think a bit more creatively: Novo Nordisk: they have deep pockets—why not invest here? (Perhaps someone from the forum could give them a call and point out the opportunity.) This auction represents a unique opportunity for all these players. It is hard to believe that only two are willing to bid—and immediately walk away in a huff if their opening offer is rejected.
2 · Reply